Belite Bio Inc Adr (BLTE)

Jan 06, 2026

Morgan Stanley initiates Belite Bio stock with Overweight rating, $191 target - Investing.com

Jan 06, 2026

Jan 04, 2026

Belite Bio (NASDAQ:BLTE) Lowered to Sell Rating by Wall Street Zen - Defense World

Jan 04, 2026

Jan 01, 2026

Morgan Stanley initiates Belite Bio stock with Overweight rating, $191 target By Investing.com - Investing.com Nigeria

Jan 01, 2026

Dec 30, 2025

Belite Bio (NASDAQ:BLTE) Sets New 12-Month HighTime to Buy? - MarketBeat

Dec 30, 2025

Dec 30, 2025

Behavioral Patterns of BLTE and Institutional Flows - Stock Traders Daily

Dec 30, 2025

Dec 29, 2025

Belite Bio (NASDAQ:BLTE) Shares Up 5.5%Should You Buy? - MarketBeat

Dec 29, 2025

Dec 29, 2025

Belite Bio stock hits all-time high at 163.25 USD - Investing.com

Dec 29, 2025

Dec 29, 2025

Belite Bio stock hits all-time high at 163.25 USD By Investing.com - Investing.com Australia

Dec 29, 2025

Dec 27, 2025

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Short Interest Down 45.2% in December - MarketBeat

Dec 27, 2025

Dec 27, 2025

Belite Bio (NASDAQ:BLTE) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Dec 27, 2025

Dec 27, 2025

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 27, 2025

Dec 27, 2025

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Dec 27, 2025

Dec 19, 2025

The $100 ClubWere You Early To The Triple-Digit Rally In ABVX, NUTX, BLTE…? - RTTNews

Dec 19, 2025

Dec 19, 2025

(BLTE) Volatility Zones as Tactical Triggers - Stock Traders Daily

Dec 19, 2025

Dec 18, 2025

Belite Bio (NASDAQ:BLTE) Sets New 1-Year HighHere's Why - MarketBeat

Dec 18, 2025

Dec 18, 2025

Can Belite Bio Inc (Common Stock) (D01) stock attract analyst upgradesMarket Movers & Expert Approved Trade Ideas - Улправда

Dec 18, 2025

Dec 18, 2025

Belite Bio, IncDepositary Receipt (BLTE) Price Target Increased by 21.98% to 116.02 - MSN

Dec 18, 2025

Dec 17, 2025

Belite Bio (NASDAQ:BLTE) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat

Dec 17, 2025

Dec 14, 2025

Belite Bio (NASDAQ:BLTE) Sets New 52-Week High – Here’s What Happened - Defense World

Dec 14, 2025

Dec 12, 2025

Belite Bio Shares Surge After Landmark Phase 3 Success in Stargardt Disease - MSN

Dec 12, 2025

Dec 12, 2025

Belite Bio (NASDAQ:BLTE) Reaches New 52-Week HighShould You Buy? - MarketBeat

Dec 12, 2025

Dec 11, 2025

Belite Bio stock hits all-time high at 160.74 USD - Investing.com

Dec 11, 2025

Dec 11, 2025

Belite Bio stock hits all-time high at 160.74 USD By Investing.com - Investing.com Canada

Dec 11, 2025

Dec 07, 2025

Price-Driven Insight from (BLTE) for Rule-Based Strategy - news.stocktradersdaily.com

Dec 07, 2025

Dec 06, 2025

Belite Bio (NASDAQ:BLTE) Stock Price Down 5.9%Should You Sell? - MarketBeat

Dec 06, 2025

Dec 05, 2025

Belite Bio (NASDAQ:BLTE) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Dec 05, 2025

Dec 05, 2025

Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Clene (CLNN) and Costco (COST) - The Globe and Mail

Dec 05, 2025

Dec 04, 2025

Belite Bio (NASDAQ:BLTE) Rating Increased to Outperform at Mizuho - MarketBeat

Dec 04, 2025

Dec 04, 2025

FY2025 EPS Estimates for Belite Bio Lowered by HC Wainwright - MarketBeat

Dec 04, 2025

Dec 04, 2025

Belite Bio (NASDAQ:BLTE) Raised to “Outperform” at Mizuho - Defense World

Dec 04, 2025

Dec 03, 2025

Belite Bio prices 2.27M ADSs at $154.00 to raise $350M in public offering - MSN

Dec 03, 2025

Dec 03, 2025

Belite Bio (NASDAQ:BLTE) Shares Gap UpWhat's Next? - MarketBeat

Dec 03, 2025

Dec 03, 2025

Belite Bio stock price target raised to $187 from $132 at Benchmark By Investing.com - Investing.com South Africa

Dec 03, 2025

Dec 03, 2025

Belite Bio stock price target raised to $187 from $132 at Benchmark - Investing.com Nigeria

Dec 03, 2025

Dec 03, 2025

Is Belite Bio’s Surge Justified by DCF Upside and Price to Book Signals? - Sahm

Dec 03, 2025

Dec 02, 2025

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Average Recommendation of “Hold” by Brokerages - Defense World

Dec 02, 2025

Dec 02, 2025

Belite Bio Reports Increased Cash Reserves Amid Rising R&D Costs - The Globe and Mail

Dec 02, 2025

Dec 02, 2025

Belite Bio Prices $350 Million ADS Offering to Boost Drug Development - TipRanks

Dec 02, 2025

Dec 02, 2025

Does Belite Bio Inc ADR (BLTE) offer a good opportunity for investors? - Setenews

Dec 02, 2025

Dec 02, 2025

Mizuho upgrades Belite Bio stock to Outperform on positive trial data By Investing.com - Investing.com South Africa

Dec 02, 2025

Dec 02, 2025

Mizuho upgrades Belite Bio stock to Outperform on positive trial data - Investing.com Australia

Dec 02, 2025

Dec 02, 2025

Why Belite Bio’s Stock is Making Waves - TipRanks

Dec 02, 2025

Dec 02, 2025

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Dec 02, 2025

Dec 01, 2025

Belite Bio prices public offering of ADSs at $154 each - Investing.com

Dec 01, 2025

Dec 01, 2025

Belite Bio prices public offering of ADSs at $154 each By Investing.com - Investing.com India

Dec 01, 2025

Dec 01, 2025

Belite Bio (NASDAQ: BLTE) prices $350M ADS offer to back commercialization, pipeline - Stock Titan

Dec 01, 2025